obstetrics-gynaecology

IOTA Simple Rules for Ovarian Mass Classification

International Ovarian Tumour Analysis (IOTA) Simple Rules classify adnexal masses as malignant (M-features), benign (B-features), or inconclusive. Applicable when using ultrasound. Sensitivity 92%, specificity 96% when applicable.

References

Timmerman D et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681–690.

Curated clinical cross-links plus same-class fallbacks.

Calculators

Risk of Malignancy Index (RMI) for Ovarian Cancer · Gynaecology Oncology
Reid's Colposcopic Index (RCI) · Gynaecology Oncology
Swede Score for Colposcopy · Gynaecology Oncology
FIGO Staging for Ovarian Cancer (2014) · Gynaecology Oncology

Drugs

Zoledronic Acid · Bisphosphonate (IV)
Denosumab · RANK Ligand Inhibitor (Anti-resorptive)
Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
Zoledronic Acid · IV Bisphosphonate
Zoledronic Acid · Bisphosphonate

Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.

References

Related